Marie Diener-West

Last updated
Marie Diener-West
Alma mater Johns Hopkins University
Loyola University of Chicago
Known for Biostatistics
Epidemiology
Collaborative Ocular Melanoma Study (COMS)
Scientific career
Fields Statistics
Biostatistics
Institutions Johns Hopkins University

Marie Diener-West is the Helen Abbey and Margaret Merrell Professor of Biostatistics and the chair of the Master of Public Health Program at Johns Hopkins Bloomberg School of Public Health. Diener-West is an editor for the Cochrane Eyes and Vision Group [1] and a member of the American Public Health Association, American Statistical Association, Association for Research in Vision and Ophthalmology, and the Society for Clinical Studies. [2]

Contents

Education and career

Diener-West earned a B.S., magna cum laude, degree in both Mathematics and Biology from Loyola University Chicago in 1977, earning the "Best Biology Student Award." [3] While working on her Ph.D., she worked as a Teaching and Research Assistant in the Departments of Biostatistics and Epidemiology at Johns Hopkins University (1978-1981) and as a Senior Statistician in the Radiation Therapy and Oncology Group at the American College of Radiology in Philadelphia (1983-1986). Diener-West went on to earn her Ph.D. in Biostatistics from the Johns Hopkins School of Hygiene and Public Health. [3]

In 1986, Diener-West was awarded a joint appointment at Johns Hopkins University as an assistant professor in both the department of Biostatistics at Johns Hopkins School of Hygiene and Public Health and the department of ophthalmology at the Johns Hopkins School of Medicine. [4] During her joint appointment, Diener-West became the Study Statistician and Deputy Director of the Coordinating Center for the Collaborative Ocular Melanoma Study (COMS) at Johns Hopkins School of Medicine, a position she held from 1986–2005. [5] In 1989, she worked for the Save the Children Federation as a statistician in Kathmandu, Nepal. [3] In 1990, Diener-West returned to her joint appointment at Johns Hopkins University, while also becoming a faculty member at the Johns Hopkins Center for Clinical Trials, a position she holds to this day. [5] During her second term as a joint associate professor, Diener-West became a member of the editorial board of the American Journal of Ophthalmology, a position she held from 1998–2004. [3]

In 2000, Diener-West was given another joint appointment at Johns Hopkins University, however, this time, she was appointed as a full professor in the departments of Biostatistics and Epidemiology at Johns Hopkins Bloomberg School of Public Health. [3] In 2004, Diener-West was appointed as the Inaugural Helen Abbey and Margaret Merrell Professor of Biostatistics Education, a position she has held to this day. [6] In 2008, Diener-West was named as the chair of the Johns Hopkins Bloomberg School of Public Health's Master of Public Health program [6]

Research area

Diener-West states that her "research interests have focused on the design, conduct, and analysis of clinical trials." [7] While working as the Study Statistician and Deputy Director of the Coordinating Center for the Collaborative Ocular Melanoma Study (COMS) at Johns Hopkins School of Medicine [5] Diener-West co-published several articles concerning the project. The subject of these articles varied greatly, she published articles concerning: "Changing current practice: Implementing large multicenter trials for a rare condition", [8] "Statistical methods for monitoring recruitment in a multi-center clinical trial.," [8] "A Review of Mortality From Choroidal Melanoma II. A Meta-Analysis of 5-Year Mortality Rates Following Enucleation, 1966 Through 1988," [9] and "Mortality after deferral of treatment or no treatment for choroidal melanoma." [10]

Diener-West has also co-published a paper concerning the treatment of cystic fibrosis entitled "Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate." [11] The study investigated the effects of an orally bioavailable short chain fatty acid called 4-phenylbutyrate, which "modulates heat shock protein expression and restores maturation of the deltaF508 [a mutation linked to cystic fibrosis] protein in vitro and in vivo," when given to subjects with cystic fibrosis. The authors concluded that the "short-term phase I/II study demonstrates proof of principle that modulation of deltaF508 CFTR biosynthesis and trafficking is a viable therapeutic approach for cystic fibrosis." [11]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Cyst</span> Closed sac growth on the body

A cyst, also traditionally known from Old English as a wen, is a closed sac, having a distinct envelope and division compared with the nearby tissue. Hence, it is a cluster of cells that have grouped together to form a sac ; however, the distinguishing aspect of a cyst is that the cells forming the "shell" of such a sac are distinctly abnormal when compared with all surrounding cells for that given location. A cyst may contain air, fluids, or semi-solid material. A collection of pus is called an abscess, not a cyst. Once formed, a cyst may resolve on its own. When a cyst fails to resolve, it may need to be removed surgically, but that would depend upon its type and location.

The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. The mission of NEI is "to eliminate vision loss and improve quality of life through vision research." NEI consists of two major branches for research: an extramural branch that funds studies outside NIH and an intramural branch that funds research on the NIH campus in Bethesda, Maryland. Most of the NEI budget funds extramural research.

The Age-Related Eye Disease Study (AREDS) was a clinical trial sponsored by the National Eye Institute that ran from 1992 to 2001. The study was designed to:

Neuro-ophthalmology is an academically-oriented subspecialty that merges the fields of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Neuro-ophthalmologists initially complete a residency in either neurology or ophthalmology, then do a fellowship in the complementary field. Since diagnostic studies can be normal in patients with significant neuro-ophthalmic disease, a detailed medical history and physical exam is essential, and neuro-ophthalmologists often spend a significant amount of time with their patients.

<span class="mw-page-title-main">Sodium phenylbutyrate</span> Chemical compound

Sodium phenylbutyrate, sold under the brand name Buphenyl among others, is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid. The compound is used to treat urea cycle disorders, because its metabolites offer an alternative pathway to the urea cycle to allow excretion of excess nitrogen.

<span class="mw-page-title-main">Alfred Sommer</span> American ophthalmologist and academic

Alfred (Al) Sommer is a prominent American ophthalmologist and epidemiologist at the Johns Hopkins Bloomberg School of Public Health. His research on vitamin A in the 1970s and 1980s revealed that dosing even mildly vitamin A deficient children with an inexpensive, large dose vitamin A capsule twice a year reduces child mortality by as much as 34 percent. The World Bank and the Copenhagen Consensus list vitamin A supplementation as one of the most cost-effective health interventions in the world.

David Lawrence Sackett was an American-Canadian physician and a pioneer in evidence-based medicine. He is known as one of the fathers of Evidence-Based Medicine. He founded the first department of clinical epidemiology in Canada at McMaster University, and the Oxford Centre for Evidence-Based Medicine. He is well known for his textbooks Clinical Epidemiology and Evidence-Based Medicine.

<span class="mw-page-title-main">Optic disc drusen</span> Medical condition

Optic disc drusen (ODD) are globules of mucoproteins and mucopolysaccharides that progressively calcify in the optic disc. They are thought to be the remnants of the axonal transport system of degenerated retinal ganglion cells. ODD have also been referred to as congenitally elevated or anomalous discs, pseudopapilledema, pseudoneuritis, buried disc drusen, and disc hyaline bodies.

<span class="mw-page-title-main">Arnall Patz</span> American physician (1920–2010)

Arnall Patz was an American medical doctor and research professor at Johns Hopkins University. In the early 1950s, Patz discovered that oxygen therapy was the cause of an epidemic of blindness among some 10,000 premature babies. Following his discovery, there was a sixty percent reduction in childhood blindness in the United States. He also conducted pioneering research in the 1960s into the use of lasers in the treatment of retinal disorders. He received the Lasker Award in 1956 for his research into the causes and prevention of blindness and the Presidential Medal of Freedom in 2004 for his lifetime of work in the field of ophthalmology.

Douglas Jabs is an American ophthalmologist and an expert in clinical research in the fields of ophthalmology and uveitis.

<span class="mw-page-title-main">Denufosol</span> Chemical compound

Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation. It was tested in two Phase III clinical trials, TIGER-1 and TIGER-2. Initially, in the first Phase III trial, TIGER-1, the compound showed significant results as compared with placebo. In the second Phase III trial, TIGER-2, the compound did not meet the primary endpoint, a significant change in baseline FEV1 at the week 48 endpoint as compared to placebo. As of 2011, no additional clinical studies are being conducted with the compound.

Kay Dickersin is an academic who trained first in cell biology and subsequently epidemiology. She went on to a career studying factors that influence research integrity, in particular publication bias and outcome reporting bias. She is retired Professor Emerita in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health where she was Director of the Center for Clinical Trials and Evidence Synthesis there. She was also Director of the US Cochrane Center and the US Satellite of the Cochrane Eyes and Vision Group within the Cochrane Collaboration. Dickersin received multiple awards for her research.

Neil R. Powe is an American professor of medicine at the University of California, San Francisco and the chief of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center. Previously he was professor of medicine at the Johns Hopkins University School of Medicine. His research has mainly related to kidney disease, cardiovascular disease and health disparities.

Cheryl Ann Marie Anderson is an American epidemiologist. Anderson is a professor at and founding Dean of the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Anderson's research focus is on nutrition and chronic disease prevention in under-served human populations.

Roger D. Peng is an author and professor of Statistics and Data Science at the University of Texas at Austin. Peng originally received a Bachelor of Science in Applied Mathematics from Yale University in 1999, before going on to study at the University of California, Los Angeles, where he completed a Master of Science in Statistics in 2001 and a PhD in Statistics in 2003. The focus of his research has been on environmental health, specifically focusing on air pollution and climate change in his research. Peng is also a software engineer who has authored numerous R packages focused on applying statistical methods necessary for a variety of topics. He has also created numerous resources including books, online courses, podcasts, blogs, and other articles to aid those learning data analysis.

<span class="mw-page-title-main">Janine Austin Clayton</span> American ophthalmologist

Janine Austin Clayton is an American ophthalmologist. She is the NIH associate director for research on women's health and director of the Office of Women's Health. Clayton was previously the deputy clinical director of the National Eye Institute.

Joanne Katz is an epidemiologist, biostatistician, and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. She holds joint appointments in the Departments of Biostatistics, Epidemiology and Ophthalmology. Her expertise is in maternal, neonatal, and child health. She has contributed to the design, conduct and analysis of data from large community based intervention trials on nutritional and other interventions in Indonesia, Philippines, Bangladesh, Nepal and other countries.

<span class="mw-page-title-main">Choroidal nevus</span> Medical condition

Choroidal nevus is a type of eye neoplasm that is classified under choroidal tumors as a type of benign (non-cancerous) melanocytic tumor. A choroidal nevus can be described as an unambiguous pigmented blue or green-gray choroidal lesion, found at the front of the eye, around the iris, or the rear end of the eye.

<span class="mw-page-title-main">Cystic fibrosis and race</span>

Underrepresented populations, especially black and hispanic populations with cystic fibrosis are often not successfully diagnosed. This is in part due to the minimal dissemination of existing data on patients from these underrepresented groups. While white populations do appear to experience a higher frequency of cystic fibrosis, other ethnicities are also affected and not always by the same biological mechanisms. Thus, many healthcare and treatment options are less reliable or unavailable to underrepresented populations. This issue affects the level at which public health needs are being met across the world.

Paul Adrian Negulescu is an American–Romanian cell biologist. He is the Senior Vice President and Site Head of the San Diego Research Center of American pharmaceutical company Vertex Pharmaceuticals. He received the 2022 Shaw Prize in Life science and medicine, together with Michael J. Welsh, for their work that uncovered the etiology of cystic fibrosis and developed effective medications.

References

  1. ↑ "More about us | Cochrane Eyes and Vision Group". Eyes.cochrane.org. 2011-12-12. Archived from the original on 2014-04-27. Retrieved 2013-10-06.
  2. ↑ "Marie Diener-West | Profile | Faculty | Center for Global Health". Hopkinsglobalhealth.org. Archived from the original on 2013-10-06. Retrieved 2013-10-06.
  3. 1 2 3 4 5 "Curriculum Vitae : Marie Diener-West" (PDF). Biostat.jhsph.edu. Retrieved 2013-10-06.
  4. ↑ "Diener-West, Marie". Hopkinsmedicine.org. Retrieved 2013-10-06.
  5. 1 2 3 "Marie Diener-West | Profile | Faculty Directory | Johns Hopkins Bloomberg School of Public Health". Jhsph.edu. Retrieved 2013-10-06.
  6. 1 2 "Marie Diener-West to Chair MPH Program - 2008 - Stories - News - Johns Hopkins Bloomberg School of Public Health". Jhsph.edu. 2008-03-14. Retrieved 2013-10-06.
  7. ↑ "Personal Website of Dr. Marie Diener-West". Biostat.jhsph.edu. Retrieved 2013-10-06.
  8. 1 2 "COMS - Publications". Jhu.edu. 1999-06-16. Retrieved 2013-10-06.
  9. ↑ Diener-West, Marie (1992). "JAMA Network | JAMA Ophthalmology | A Review of Mortality From Choroidal Melanoma: II. A Meta-Analysis of 5-Year Mortality Rates Following Enucleation, 1966 Through 1988". Archives of Ophthalmology. 110 (2): 245–50. doi:10.1001/archopht.1992.01080140101036. PMID   1531290.
  10. ↑ Straatsma, B. R.; Diener-West, M.; Caldwell, R.; Engstrom, R. E.; Collaborative Ocular Melanoma Study Group (2003). "Elsevier". American Journal of Ophthalmology. 136 (1): 47–54. doi:10.1016/S0002-9394(02)02270-5. PMC   6173014 . PMID   12834669.
  11. 1 2 Zeitlin, PL; Diener-West, M; Rubenstein, RC; Boyle, MP; Lee, CK; Brass-Ernst, L (2013-03-25). "Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate". Mol Ther. 6 (1): 119–26. doi: 10.1006/mthe.2002.0639 . PMID   12095312.
  12. ↑ Steinberg, Earl P. (1991-12-15). "JAMA Network | JAMA Ophthalmology | The VF-14: An Index of Functional Impairment in Patients With Cataract". Archives of Ophthalmology. 112 (5): 630–638. doi:10.1001/archopht.1994.01090170074026. PMID   8185520.
  13. ↑ Burstein, Gale R. (1998). "JAMA Network | JAMA | Incident Chlamydia trachomatis Infections Among Inner-city Adolescent Females". JAMA. 280 (6): 521–6. doi: 10.1001/jama.280.6.521 . PMID   9707141.
  14. ↑ Garg, Pushkal P.; Frick, Kevin D.; Diener-West, Marie; Powe, Neil R. (1999). "Effect of the Ownership of Dialysis Facilities on Patients' Survival and Referral for Transplantation". New England Journal of Medicine. 341 (22): 1653–1660. doi: 10.1056/NEJM199911253412205 . PMID   10572154.
  15. ↑ Amarasingham, Ruben; Plantinga, Laura; Diener-West, Marie; Gaskin, Darrell J.; Powe, Neil R. (2009). "JAMA Network | JAMA Internal Medicine | Clinical Information Technologies and Inpatient Outcomes: A Multiple Hospital Study". Archives of Internal Medicine. 169 (2): 108–14. doi: 10.1001/archinternmed.2008.520 . PMID   19171805.
  16. ↑ Diener-West, Marie; Dobbins, Thomas W.; Phillips, Theodore L.; Nelson, Diana F. (1989). "Elsevier". International Journal of Radiation Oncology, Biology, Physics. 16 (3): 669–673. doi:10.1016/0360-3016(89)90483-5. PMID   2646260 . Retrieved 2013-10-06.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.